viernes, 19 de diciembre de 2014

Drug Safety Update Volume 8, Issue 5, December 2014

Boletín mensual de  la agencia británica, Medicines and Healthcare products Regulatory Agency y su comiité asesor  Commission on Human Medicines

18 de diciembre , 2014


Drug safety advice
Ivabradine (Procoralan) in the symptomatic treatment of angina: risk of cardiac side effects—new advice to minimise risk A1
Isotretinoin (Roaccutane): reminder of possible risk of psychiatric disorders — warn patients and family; monitor patients for signs of
depression A2
Hydroxyethyl starch intravenous infusions to be used only in patients with acute blood loss and when crystalloids alone are not sufficient A3
Hydrogen peroxide: reminder of risk of gas embolism when used in surgery –do not use in closed body cavities or on deep or large wounds A4
Veletri (epoprostenol) powder for solution for infusion: incompatibilities with some models of administration devices A5

otra información de MHRA
Drug Safety Update is moving to GOV.UK O1